US FDA approves ViiV Healthcare’s Cabenuva as complete long-acting regimen for HIV treatment EP News Bureau Jan 22, 2021 Cabenuva allows virologically suppressed adults living with HIV without prior treatment failure or resistance to cabotegravir or…
